日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The resistance risk of fluopicolide and resistance-associated point mutations in the target protein PlVHA-a in Phytophthora litchii

荔枝疫霉菌中氟吡啶类抗生素的耐药风险及靶蛋白PlVHA-a中与耐药相关的点突变

期刊:Stress Biology
影响因子:5.8
doi:10.1007/s44154-025-00218-9
Dai, Tan; Yang, Jikun; Hu, Shiping; Zhao, Chuang; Yuan, Kang; Miao, Jianqiang; Liu, Xili
发表日期：2025
文献求助 收藏

In silico and in vivo verification of the mechanism of formononetin in treating hepatocellular carcinoma.

通过计算机模拟和体内实验验证芒柄花素治疗肝细胞癌的机制

期刊:Annals of Medicine
影响因子:4.3
doi:10.1080/07853890.2024.2404550
Ma Guiping, Pang Xu, Ran Yun, Chen Wenlin, Zhou Yichi, Li Xiaobin, Liu Bowen, Li Feng, Hu Shiping
细胞生物学
发表日期：2024
文献求助 收藏

Efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of randomized controlled trials

二线治疗晚期肝细胞癌的疗效和安全性：一项随机对照试验的网络荟萃分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12780-y
Lu, Fenping; Zhao, Kai; Ye, Miaoqing; Xing, Guangyan; Liu, Bowen; Li, Xiaobin; Ran, Yun; Wu, Fenfang; Chen, Wei; Hu, Shiping
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Extracellular vesicle dynamics in COPD: understanding the role of miR-422a, SPP1 and IL-17 A in smoking-related pathology

慢性阻塞性肺病中的细胞外囊泡动力学：了解 miR-422a、SPP1 和 IL-17 A 在吸烟相关病理中的作用

期刊:BMC Pulmonary Medicine
影响因子:2.6
doi:10.1186/s12890-024-02978-y
Zhihui Dai #, Li Lin #, Yanan Xu, Lifang Hu, Shiping Gou, Xinkai Xu
囊泡
细胞生物学
其它细胞
发表日期：2024
文献求助 收藏

CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment

CELSR3是头颈部鳞状细胞癌的预后标志物，与肿瘤微环境中的免疫细胞浸润相关。

期刊:European Archives of Oto-Rhino-Laryngology
影响因子:2.2
doi:10.1007/s00405-024-08566-4
Wu, Zhongbiao; Zhu, Zhongyan; Wu, Weikun; Hu, Shiping; Cao, Jian; Huang, Xinmei; Xie, Qiang; Deng, Chengcheng
肿瘤
肿瘤免疫
CEL
细胞生物学
肿瘤微环境
免疫/内分泌
发表日期：2024
文献求助 收藏

SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment

SLA2是头颈部鳞状细胞癌的预后标志物，与肿瘤微环境中的免疫细胞浸润相关。

期刊:European Archives of Oto-Rhino-Laryngology
影响因子:2.2
doi:10.1007/s00405-023-08213-4
Wu, Zhongbiao; You, Chengkun; Zhu, Zhongyan; Wu, Weikun; Cao, Jian; Xie, Qiang; Deng, Chengcheng; Huang, Xinmei; Hu, Shiping
肿瘤
肿瘤免疫
细胞生物学
肿瘤微环境
免疫/内分泌
发表日期：2024
文献求助 收藏

[Retracted] MicroRNA‑326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1

[已撤稿] MicroRNA-326 通过直接靶向 LIM 和 SH3 蛋白抑制肝细胞癌细胞增殖和侵袭，并激活其凋亡 1

期刊:Oncology Reports
影响因子:3.9
doi:10.3892/or.2023.8524
Hu, Shiping; Ran, Yun; Chen, Wenlin; Zhang, Yuncheng; Xu, Yongjian
凋亡
肿瘤
表观遗传
肿瘤免疫
细胞生物学
发表日期：2023
文献求助 收藏

PSMC2 knockdown exerts an anti-tumor role in nasopharyngeal carcinoma through regulating AKT signaling pathway

敲低PSMC2通过调控AKT信号通路在鼻咽癌中发挥抗肿瘤作用

期刊:Cell Cycle
影响因子:3.4
doi:10.1080/15384101.2023.2293590
Jin Su, Shousen Hu, Shiping Ding, Kun Feng
信号转导
肿瘤
鼻咽癌
PI3K/Akt
发表日期：2023
文献求助 收藏

Prediction of network pharmacology, molecular docking-based strategy, and vitro assays to determine potential pharmacological mechanism of Dioscoreae bulbiferae and Bruceae fructus against laryngocarcinoma.

通过网络药理学、基于分子对接的策略和体外试验预测薯蓣和布鲁斯果对抗喉癌的潜在药理机制

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000036771
Wu Zhongbiao, Zhu Zhongyan, Cao Jian, Wu Weikun, Deng Chengcheng, Xie Qiang, Hu Shiping
肿瘤
发表日期：2023
文献求助 收藏

Prediction of network pharmacology and molecular docking-based strategy to determine potential pharmacological mechanism of Liuwei Dihuang pill against tinnitus

基于网络药理学和分子对接策略的预测，用于确定六味地黄丸治疗耳鸣的潜在药理机制

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000031711
Wu, Zhongbiao; Zhu, Zhongyan; Cao, Jian; Wu, Weikun; Hu, Shiping; Deng, Chengcheng; Xie, Qiang; Huang, Xinmei; You, Chengkun
发表日期：2022
文献求助 收藏